( NYSE:SNY )

News from sanofi us A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 14, 2015, 06:30 ET Validus Pharmaceuticals Further Expands Marketed U.S. Portfolio with Product Lines Purchased from Leading Healthcare Company

Validus Pharmaceuticals LLC ("Validus"), together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the...


Dec 14, 2015, 06:30 ET Validus Pharmaceuticals Further Expands Marketed U.S. Portfolio with Product Lines Purchased from Leading Healthcare Company

Validus Pharmaceuticals LLC ("Validus"), together with Wood Creek Capital Management, LLC ("Wood Creek"), announced today the acquisition of the...


Apr 15, 2014, 09:00 ET Basketball Hall of Famer Nancy Lieberman Teams Up with New Nasacort® Allergy 24HR to Help Allergy Sufferers Put the Full 'Cort Press on Nasal Allergy Symptoms

 Nancy Lieberman, basketball hall of famer, coach and mom, has teamed up with Sanofi's consumer healthcare division Chattem Inc. to introduce a...


Feb 04, 2014, 11:43 ET Sanofi's Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without a Prescription in the U.S.

Sanofi (EURONEXT: SAN and NYSE: SNY) and its U.S. consumer healthcare division Chattem announced today that Nasacort® Allergy 24HR Nasal Spray...


Dec 05, 2013, 08:00 ET New Data Support Flexibility in Timing of Administration for Sanofi's Lyxumia®

 Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the results of a 24-week Phase IIIb clinical study showing that Lyxumia®...


Dec 03, 2013, 08:00 ET Sanofi Announces New Phase 3 Results for Investigational New Insulin U300

 Sanofi announced the full results from the EDITION II study showing that investigational new insulin U300 demonstrated similar blood sugar...


Oct 01, 2013, 09:00 ET HuREL® Enters Into Cell-Based R&D Collaboration With Sanofi US To Validate HuRELhuman™ In Vitro Liver Tissue Co-Culture For Use In Pre-Clinical Drug Development

HuREL Corporation ("Hurel"), a world-leading provider of advanced tissue constructs and microfluidic cell-based assay platforms for pre-clinical...